NCT01398956 - An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

EpilepsyGeneralized Tonic-clonic Seizures

Interventions

DRUG

Levetiracetam

"formulation: tablet or dry syrup~strength: 250 mg tablet, 500 mg tablet, dry syrup 50%~dosage: Sb ≥16 years and ≥4 and \<16 years (≥50 kg): 1000 mg/day, 2000 mg/day or 3000 mg/day; Sb ≥4 and \<16 years (\<50kg): 20 mg/kg/day, 40 mg/kg/day, or 60 mg/kg/day~frequency: twice daily"

Trial Locations (32)

Unknown

152, Fujisawa

112, Fukuoka

113, Fukuoka

165, Fukuoka

166, Fukuoka

187, Fukushima

107, Gifu

162, Himeji

110, Hiroshima

117, Hokkaido

130, Hokkaido

176, Hokkaido

143, Kagoshima

156, Kagoshima

120, Kodaira

105, Kokubunji

306, Kōshi

172, Miyazaki

179, Miyazaki

305, Nagoya

106, Niigata

153, Niigata

109, Okayama

174, Osaka

119, Saitama

147, Sakai

194, Sakai

304, Sapporo

138, Tochigi

184, Tokyo

190, Tokyo

111, Ube